Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

SMFR


Top 10 Correlated ETFs

SMFR


Top 10 Correlated Stocks

SMFR


In the News

11:32 04 Oct 2022 SMFR

Why Sema4 Holdings Stock Is Crashing Today

The healthcare company delivered plenty of bad news in its Q2 update.

09:29 04 Oct 2022 SMFR

Sema4 Holdings Corp (SMFR) CEO Katherine Stueland on Q2 2022 Results - Earnings Call Transcript

Sema4 Holdings Corp (NASDAQ:SMFR ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Joel Kaufman - VP, Finance & Corporate Development Katherine Stueland - CEO & Director Kevin Feeley - SVP, Operations and Head of GeneDx Conference Call Participants David Delahunt - Goldman Sachs Group Matt Kim - Jeffrey Max Masucci - Cowen and Company Mark Massaro - BTIG Operator Good day, and thank you for standing by. Welcome to the Sema4 Second Quarter 2022 Earnings Conference Call.

12:02 04 Oct 2022 SMFR

Sema4 Holdings, Big Data For Precision Medicine Solutions

Big data and machine learning are booming also in healthcare, where it enables precision medicine and population health platform services. Sema4 Holdings has amassed huge amounts of medical data and a sophisticated platform in order to extract valuable insight from these for health systems, pharma companies and individuals.

01:27 04 Oct 2022 SMFR

Sema4 Holdings Corp. (SMFR) Moves to Buy: Rationale Behind the Upgrade

Sema4 Holdings Corp. (SMFR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

10:52 04 Oct 2022 SMFR

Sema4 Holdings Corp. (SMFR) CEO Katherine Stueland on Q1 2022 Results - Earnings Call Transcript

Sema4 Holdings Corp. (NASDAQ:SMFR ) Q1 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Representatives Katherine Stueland - Chief Executive Officer Eric Schadt - Founder, President and Chief R&D Officer Isaac Ro - Chief Financial Officer Joel Kaufman - Vice President of Finance and Corporate Development Conference Call Participants Mark Massaro - BTIG Max Masucci - Cowen and Company Dave Delahunt - Goldman Sachs Operator Good day! And thank you for standing by.

07:57 04 Oct 2022 SMFR

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q4 2021 Results - Earnings Call Transcript

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q4 2021 Results - Earnings Call Transcript

09:39 04 Oct 2022 SMFR

Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition

Sema4 Holdings Corp (NASDAQ: SMFR) has agreed to acquire OPKO Health Inc's (NASDAQ: OPK) wholly-owned subsidiary, GeneDx Inc, for approximately $623 million. Sema4 will acquire GeneDx for an upfront payment of $150 million in cash plus 80 million shares in Sema4, with up to an additional $150 million revenue-based milestones over the next two years.

07:36 04 Oct 2022 SMFR

Sema4 Stock (SMFR): Why The Price Jumped

The stock price of Sema4 Holdings Corp (NASDAQ: SMFR) increased by 13.63% in the most recent trading session. This is why it happened.

09:14 04 Oct 2022 SMFR

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q3 2021 Results - Earnings Call Transcript

Sema4 Holdings Corp. (SMFR) CEO Eric Schadt on Q3 2021 Results - Earnings Call Transcript

12:09 04 Oct 2022 SMFR

Why Sema4 Holdings Stock Is Sinking Today

Investors weren't happy with the company's Q2 update.

Financial details

Company Rating
Neutral
Market Cap
334.01M
Income
-301.22M
Revenue
147.91M
Book val./share
2.64
Cash/share
1.18
Dividend
-
Dividend %
-
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
-0.73
Forward P/E
-
PEG
-0
P/S
1.48
P/B
0.34
P/C
0.75
P/FCF
-0.59
Quick Ratio
1.62
Current Ratio
1.97
Debt / Equity
0.12
LT Debt / Equity
0.12
-
-
EPS (TTM)
-1.08
EPS next Y
-
EPS next Q
-
EPS this Y
127545.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-32.95%
EPS Q/Q
137.5%
-
-
-
-
SMA20
-
SMA50
-50%
SMA100
-50%
Inst Own
65.86%
Inst Trans
-34.14%
ROA
-32%
ROE
-89%
ROC
-0.63%
Gross Margin
-10%
Oper. Margin
-309%
Profit Margin
-204%
Payout
-
Shs Outstand
380.64M
Shs Float
257.64M
-
-
-
-
Target Price
3.25
52W Range
0.83-9.18
52W High
-
52W Low
-
RSI
37
Rel Volume
0.81
Avg Volume
1.38M
Volume
1.12M
Perf Week
-2.9%
Perf Month
-25.78%
Perf Quarter
-66.16%
Perf Half Y
-70.95%
-
-
-
-
Beta
-
-
-
Volatility
0.02%, 0.1%
Prev Close
0.65%
Price
0.8832
Change
-3.97%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2021-12-31
Revenue per share
0.88
Net income per share
-1.02
Operating cash flow per share
-0.79
Free cash flow per share
-0.88
Cash per share
1.67
Book value per share
1.62
Tangible book value per share
1.62
Share holders equity per share
1.62
Interest debt per share
0.15
Market cap
737.38M
Enterprise value
369.66M
P/E ratio
-3
Price to sales ratio
3.48
POCF ratio
-3.87
PFCF ratio
-3.49
P/B Ratio
1.9
PTB ratio
1.9
EV to sales
1.74
Enterprise value over EBITDA
-1.67
EV to operating cash flow
-1.94
EV to free cash flow
-1.75
Earnings yield
-0.33
Free cash flow yield
-0.29
Debt to equity
0.08
Debt to assets
0.3
Net debt to EBITDA
1.67
Current ratio
4.77
Interest coverage
-157.37
Income quality
0.78
Dividend Yield
0
Payout ratio
0
Sales general and administrative to revenue
0.97
Research and developement to revenue
0.5
Intangibles to total assets
0
Capex to operating cash flow
0.11
Capex to revenue
-0.1
Capex to depreciation
-0.95
Stock based compensation to revenue
1.03
Graham number
6.09
ROIC
-0.99
Return on tangible assets
-0.44
Graham Net
1.13
Working capital
382.26M
Tangible asset value
0
Net current asset value
317.55M
Invested capital
0.08
Average receivables
0
Average payables
0
Average inventory
0
Days sales outstanding
45.69
Days payables outstanding
71.3
Days of inventory on hand
53.37
Receivables turnover
7.99
Payables turnover
5.12
Inventory turnover
6.84
ROE
-0.63
Capex per share
-0.09

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
0.200.240.220.15
Net income per share
-0.190-0.17-0.32-0.76
Operating cash flow per share
0-0.74-0.22-0.34-0.35
Free cash flow per share
0-0.76-0.25-0.34-0.36
Cash per share
0.1101.661.31.18
Book value per share
-2.3501.611.362.64
Tangible book value per share
-2.3501.611.361.09
Share holders equity per share
-2.3501.611.362.64
Interest debt per share
0.0800.140.310.33
Market cap
3.37B1.41B1.08B741.38M304.28M
Enterprise value
3.36B1.41B709.33M499.93M98.19M
P/E ratio
-18.550-6.66-2.41-0.41
Price to sales ratio
71.8018.6313.748.41
POCF ratio
-3.63K-10.25-20.72-9.1-3.59
PFCF ratio
-3.63K-9.93-18.05-8.95-3.54
P/B Ratio
-5.963.6K2.782.250.48
PTB ratio
-5.963.6K2.782.250.48
EV to sales
71.62012.279.272.71
Enterprise value over EBITDA
-75.1987.99-20.91-7.11-0.73
EV to operating cash flow
-3.62K-10.24-13.64-6.13-1.16
EV to free cash flow
-3.62K-9.93-11.89-6.03-1.14
Earnings yield
-0.010-0.04-0.1-0.6
Free cash flow yield
0-0.1-0.06-0.11-0.28
Debt to equity
-0.030.030.080.210.12
Debt to assets
4.220.350.30.360.32
Net debt to EBITDA
0.19-0.0310.843.441.54
Current ratio
1.397.554.774.081.97
Interest coverage
-61.840-164.1-110.53-205.88
Income quality
0.0201.291.060.46
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.27010.791.88
Research and developement to revenue
0.2600.380.40.75
Intangibles to total assets
00000.4
Capex to operating cash flow
00.030.150.020.02
Capex to revenue
00-0.13-0.03-0.04
Capex to depreciation
0-0.27-1.33-0.24-0.15
Stock based compensation to revenue
000.640.330.63
Graham number
3.1602.463.136.72
ROIC
-0.43-168.43-0.26-0.21-0.22
Return on tangible assets
-0.260-0.07-0.15-0.33
Graham Net
-2.8301.120.720.18
Working capital
27.98M467.15K382.26M309.79M198.1M
Tangible asset value
0000262.43M
Net current asset value
-641.44M326.42K317.55M222.2M106.7M
Invested capital
-0.030.030.080.220.12
Average receivables
31.32M18.83M32.1M37.64M41.72M
Average payables
56.27M056.79M68.88M92.38M
Average inventory
32.72M18.17M34.89M36.32M38.96M
Days sales outstanding
48.02041.3662.81113.97
Days payables outstanding
79.15082.76128.31158.58
Days of inventory on hand
52.82061.9567.6556.93
Receivables turnover
1.8702.181.430.79
Payables turnover
1.1401.090.70.57
Inventory turnover
1.701.451.331.58
ROE
0.080-0.1-0.23-0.29
Capex per share
0-0.02-0.03-0.01-0.01

Frequently Asked Questions

What is Sema4 Holdings Corp. stock symbol ?

Sema4 Holdings Corp. is a US stock , located in Stamford of Ct and trading under the symbol SMFR

Is Sema4 Holdings Corp. buy or a sell ?

2 stock analysts have 2 predictions with a medium analyst target price of $3.25. The lowest prediction is $3 and the highest is $3.5

What is SMFR stock prediction ?

With a median analyst target price of $3, 1 stock analysts have made 1 forecasts in last 90 days. $3 is the lowest and $3 is the greatest projection.

What is Sema4 Holdings Corp. stock quote today ?

Sema4 Holdings Corp. stock price is $0.8832 today.

Is Sema4 Holdings Corp. stock public?

Yes, Sema4 Holdings Corp. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap